Presentation is loading. Please wait.

Presentation is loading. Please wait.

P1-021: Clinical Feature and Effectiveness of Chemotherapy in Elderly Lung Cancer Patients  Kyoungju Lee, Jinyong Jung, Sungyong Lee, Sangyeub Lee, Jehyeong.

Published byJemima Curtis Modified over 6 years ago

Similar presentations

Presentation on theme: "P1-021: Clinical Feature and Effectiveness of Chemotherapy in Elderly Lung Cancer Patients  Kyoungju Lee, Jinyong Jung, Sungyong Lee, Sangyeub Lee, Jehyeong."— Presentation transcript:

1 P1-021: Clinical Feature and Effectiveness of Chemotherapy in Elderly Lung Cancer Patients 
Kyoungju Lee, Jinyong Jung, Sungyong Lee, Sangyeub Lee, Jehyeong Kim, Chol Shin, Jaejeong Shim, Kwangho In, Kyungho Kang, Sehwa Yoo  Journal of Thoracic Oncology  Volume 2, Issue 8, Pages S557-S558 (August 2007) DOI: /01.JTO Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

2 Journal of Thoracic Oncology 2007 2, S557-S558DOI: (10. 1097/01. JTO
Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

3 Journal of Thoracic Oncology 2007 2, S557-S558DOI: (10. 1097/01. JTO
Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "P1-021: Clinical Feature and Effectiveness of Chemotherapy in Elderly Lung Cancer Patients  Kyoungju Lee, Jinyong Jung, Sungyong Lee, Sangyeub Lee, Jehyeong."

Similar presentations

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages 1862-1863.

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages
Two Classic Lyrics Joined by a Contemporary Tune—Environmental Pro-Carcinogen Exposure and Genetic Susceptibility in Lung Cancer Risk  Ping Yang, MD,

Two Classic Lyrics Joined by a Contemporary Tune—Environmental Pro-Carcinogen Exposure and Genetic Susceptibility in Lung Cancer Risk  Ping Yang, MD,
Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection.

Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection.
Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection.

Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection.
E13-01: Insights into thymic epithelial tumor: pathology

E13-01: Insights into thymic epithelial tumor: pathology
SC17.02 Lung Cancer in China: Challenges and Perspectives

SC17.02 Lung Cancer in China: Challenges and Perspectives
James B. Yu, MD, Lynn D. Wilson, MD, MPH, Frank C. Detterbeck, MD 

James B. Yu, MD, Lynn D. Wilson, MD, MPH, Frank C. Detterbeck, MD 
ALK FISH and IHC: You Cannot Have One without the Other

ALK FISH and IHC: You Cannot Have One without the Other
Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer  Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.

Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer  Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.
The BIM Deletion Polymorphism and its Clinical Implication in Patients with EGFR- Mutant Non–Small-Cell Lung Cancer Treated with EGFR Tyrosine Kinase Inhibitors 

The BIM Deletion Polymorphism and its Clinical Implication in Patients with EGFR- Mutant Non–Small-Cell Lung Cancer Treated with EGFR Tyrosine Kinase Inhibitors 
Brett W. Carter, MD, Edith M. Marom, MD, Frank C. Detterbeck, MD 

Brett W. Carter, MD, Edith M. Marom, MD, Frank C. Detterbeck, MD 
APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26

APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26
Joachim Pfannschmidt, MD, Hans Hoffmann, MD, Hendrick Dienemann, MD 

Joachim Pfannschmidt, MD, Hans Hoffmann, MD, Hendrick Dienemann, MD 
P2-090: Expression of cellular retinol binding protein-1 is associated with poor prognosis of stage I non-small cell lung cancer  Moo Suk Park, Yoon Soo.

P2-090: Expression of cellular retinol binding protein-1 is associated with poor prognosis of stage I non-small cell lung cancer  Moo Suk Park, Yoon Soo.
P1.03-039 Is It Necessary to Repeat Lung Cancer Screening with Low-Dose CT(LDCT) in Female Never Smokers?  Hyae Young Kim, Kyu-Won Jung, Kun Young Lim,

P Is It Necessary to Repeat Lung Cancer Screening with Low-Dose CT(LDCT) in Female Never Smokers?  Hyae Young Kim, Kyu-Won Jung, Kun Young Lim,
NA  Journal of Thoracic Oncology 

NA  Journal of Thoracic Oncology 
Electronic Updates for JTO Readers

Electronic Updates for JTO Readers
IA05.01 Lung Cancer Cases Journal of Thoracic Oncology

IA05.01 Lung Cancer Cases Journal of Thoracic Oncology
Journal of Thoracic Oncology

Journal of Thoracic Oncology
The Influence of the Evolution of First-Line Chemotherapy on Steadily Improving Survival in Advanced Non-Small-Cell Lung Cancer Clinical Trials  Krista.

The Influence of the Evolution of First-Line Chemotherapy on Steadily Improving Survival in Advanced Non-Small-Cell Lung Cancer Clinical Trials  Krista.

Similar presentations

Ads by Google